Concepedia

Author

Andrew Wotherspoon

Royal Marsden Hospital

Also Known As

A C Wotherspoon, A Wotherspoon, A. C. WOTHERSPOON, A. C. Wotherspoon, A. Wotherspoon, A.C Wotherspoon, A.C. WOTHERSPOON, A.C. Wotherspoon, Andrew C Wotherspoon, Andrew C. Wotherspoon

420

Publications

18.8K

Citations

70

H-Index

116

Concepts

All Affiliations

Royal Marsden HospitalRoyal Marsden NHS Foundation TrustInstitute of Cancer ResearchUniversity College LondonUniversity of Cambridge
AW

About

Andrew Wotherspoon is an author at Royal Marsden Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

42

77

6.5K

2

Health Sciences

14

17

1.6K

3

Engineering

3

3

128

4

Natural Sciences

1

1

18

5

Public Health

1

1

27

Andrew Wotherspoon

×

176

Publications

14.5K

Citations

64

H-Index

YearCitations

Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial

Ian Chau, David Cunningham, David González,

The Lancet Oncology

2013

723

Mismatch Repair Deficiency, Microsatellite Instability, and Survival

Elizabeth Smyth, Andrew Wotherspoon, Clare Peckitt,

JAMA Oncology

2017

509

Neoadjuvant Capecitabine and Oxaliplatin Followed by Synchronous Chemoradiation and Total Mesorectal Excision in Magnetic Resonance Imaging–Defined Poor-Risk Rectal Cancer

Ian Chau, Gina Brown, David Cunningham,

Journal of Clinical Oncology

2006

477

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

Frederick Arce Vargas, Andrew J.S. Furness, Isabelle Solomon,

Immunity

2017

425

Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases

Sophia Frentzas, Ève Simoneau, Victoria L. Bridgeman,

Nature Medicine

2016

423

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Alice Dewdney, David Cunningham, Josep Tabernero,

Journal of Clinical Oncology

2012

387

EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT

A. Ruskoné-Fourmestraux, Wolfgang Fischbach, B.M.P. Aleman,

Gut

2011

366

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Emanuele Zucca, Luca Arcaini, Christian Buske,

Annals of Oncology

2020

323

Neoadjuvant capecitabine and oxaliplatin before chemoradiotherapy and total mesorectal excision in MRI-defined poor-risk rectal cancer: a phase 2 trial

Yu Jo Chua, Yolanda Barbáchano, David Cunningham,

The Lancet Oncology

2010

319

ESMO Consensus conferences: guidelines on malignant lymphoma. part 2: marginal zone lymphoma, mantle cell lymphoma, peripheral T-cell lymphoma

Martin Dreyling, Catherine Thiéblemont, Andrea Gallamini,

Annals of Oncology

2013

305

Page 1